,
PINK CURRENT
Click links below for latest information from Dr. Dalton
Dr. David Daltons Linkedin account
https://www.otcmarkets.com/stock/UNVC/profile
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
May 2, 2022 Univec Appoints Lauren Herron Vice President
Univec Appoints Lauren Herron Vice President | UNVC - UNIVEC, Inc. | News | OTC Markets
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
March 30, 2022 Univec Inc appoints Lamont Ellis President
Univec Appoints Lamont Ellis President | UNVC - UNIVEC, Inc. | News | OTC Markets
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Dr Dalton received a "100 top healthcare leaders" award at theIFAH 2019 and a "Top 100 Healthcare Visionary"award atthe IFAH 2021
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Leaders in Health Industry Join Forces to Address Mental Health and Substance Use Disorder UNIVEC, Inc. and bioRemedies MD Align to Introduce products offering safe alternative to pain, anxiety and sleep disorders Baltimore, MD (October 28, 2021) – Dr. David Dalton, CEO of UNIVEC, Inc. (OTC Markets:(UNVC) and Patrick Kelly, President of bioRemedies MD, LLC announced a breakthrough partnership to offer safe adjunct therapies for pain, anxiety and sleep disorders in the behavioral health setting. Through a variety of proprietary formulated cannabinoid-based products developed by bioRemedies MD, Univec, Inc. is prepared to begin using these products in clinical behavioral health settings for out-patient treatment. bioRemedies MD specializes in Cannabinoid complementary and integrative products that have been in research and development at the University of Maryland Baltimore BioPark since 2016 after industrial hemp research was legitimized. bioRemedies MD develops scientifically formulated cannabinoid products using FDA and Pharmaceutical processes, technology, and standards to ensure high quality, reproducible, and targeted formulations unlike anything in the market today. Their proprietary nanotechnology delivers cannabinoids efficiently and effectively, which is required for academic research and healthcare target markets and allows our commercial products to compete on quality
and cost. Univec, Inc. (OTC Markets:(UNVC) is an organization with a mission to change the way healthcare is delivered in
America. Having recently announced the acquisition of several community based out-patient mental health centers to treat
behavioral health. bioRemedies MD compliments Univec, Inc. (UNVC) principles--treating the patient as whole and applying
“Total Wraparound” for patient, family and caregiver support. Patrick Kelly, President of bioRemedies MD, LLC, remarked,
“the time is now to bring these products to the community weary from substance use disorders and barriers to mental health
treatment. This partnership with Univec, Inc. meets people where they are to help those suffering from pain, opioid misuse,
anxiety and sleep disorders. Univec, Inc. will make private label and bioRemedies MD products available through several
distribution channels, including the recently acquired mental health centers. For additional information about access to
treatment, contact For more information call 410-340-5360 or email pat@bioremmd.com.
https://www.otcmarkets.com/otcapi/company/dns/news/document/54281/content
UNIVEC,INC. ACQUISITION OF MENTAL HEALTH CLINICSPress Release|08/16/2021
Univec,Inc Acquisition of Mental Health Clinics
binding term sheet for the acquisition of accredited outpatient mental health centers in Maryland. These centers are community based centers which provide outpatient mental health counseling treatment for substance abuse and other ancillary services. The acquisition will add in excess of $17million in topline revenue to Univec and is expected to close on or around September 30, 2021 subject to final due diligence and valuation.
Owings Mills, MD. August 16, 2021 Univec, Inc. (OTCMarkets:UNVC) is pleased to announce the signing of a
Dr. David Dalton, CEO of Univec, stated that "This is the beginning of Univec's business plan for "Wraparound Services" in the mental health and substance abuse environment. We are in the midst of a mental health and substance abuse pandemic and new ideas are needed to address the problem. Univec intends to be at the forefront of delivering targeted care in the mental health arena by treating multiple aspects of the issues."
Univec,Inc. (UNVC)
Univec,Inc. (UNVC) is an organization whose mission is to change the way healthcare is delivered in America. We are expanding solutions in the substance abuse arena for medication and to include mental and physical healthcare, telehealth services and technology systems and solutions. Univec treats the patient as a whole to improve outcomes for our patients and clients "Total Wraparound" is the foundation for patient support.
On behalf of the Board of Directors
Dr. David Dalton
****Older News****
Dr. David Dalton announces Kenneth Grant past Vice President of Johns Hopkins Health System Joins Board of Directors
Health System Joins Board of Directors
Dr. David Dalton announces Kenneth Grant past Vice President of Johns Hopkins
Owing Mills, MD (PRUnderground) September 2nd, 2019
Dr. David Dalton, President/CEO of Univec Conglomerate Inc. states ” We are delighted to welcome Kennnet Grant past Vice President of Johns Hopkins Health System to our Board of Directors. He brings extensive knowledge and many years of demonstrated professional skills in supply chain management in healthcare to the company.” Kenneth Grant was also responsible for Community Health Initiatives for the Johns Hopkins Health System. He did oversee over 600 employees responsible for carrying out these important functions. He also had oversight for the procurement of goods and services totaling in excess of $1.0 billion dollars. Over the course of his career Ken has been recognized and has received many awards both local and national.
UNIVEC CONGLOMERATE INC. Adds Past Vice President of Merck to Board of Directors
JOHN C. PEOPLES past vice president of Merck joins the Board of Directors of Univec Conglomerate Inc.
OWINGS MILLS, Md. (PRWEB) June 06, 2019
John C. Peoples, Past Vice President of Merck joins the Board of Directors of Univec Conglomerate Inc. bringing demonstratedprofessional skills in marketing management.
pain and addiction treatment through transdermal delivery.
Univec Conglomerate Inc. is a specialty pharmaceutical and cannabis company that has focus on medication for
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
About Dr. David Dalton:UnivecCEO and President
Dr. David Dalton, The first black pharmaceutical executive in the chain drug industry. Honored as one of the top ten graduates over a 100 year span. In 3 Halls
of Fame, Senatorial Medal of Freedom and Veteran. Top 100 Healthcare leaders
and Visionary (IFAH) He served in several capacities with Rite Aid Corporation
including Corporate Vice President. He left Rite Aid Corporation to acquire
Peoples Drug Stores with investment Group inclusive of Robert Bass of Texas. Dr.
Dalton served as Senior Vice President. He founded Managed Care Rx merged it
with Bergen Brunswick, a drug wholesale company sales in excess of 14 billion.
Health Resources, Inc. for which he is Founder, President and CEO is a national
PBM and Pharmacy Services, Inc. a prescription mail service company. Health
Resources Inc. has been recognized in Black Enterprise Magazine top 100 for
over 25 years. Dr. Dalton is President and CEO of Univec,Inc. (UNVC) a public
company which manufactures and distributes specialty transdermal
pharmaceuticals and cannabis CBD. Physician and Pharmaceutical Services Inc,
(PPSI) is the pharmacy sample services division of Univec, Inc. He is Executive
Chairman of Wellness TeleHealth(TeleHealth) and WellnessRx (Mental Health and
Substance misuse clinics) Dr. Dalton is one of the original members and directors
of the National Council of Prescription Drug Programs (NCPDP). Founder of
National Minority Health Association (NMHA). He has received national and local
recognition by the President and Senate of the United States and Congressional
Black Caucus. The University of West Virginia recognized him as a Distinguished
Alumni and again honored him as Outstanding Alumni of West Virginia School of
Pharmacy and Outstanding Service recognition to the School of Pharmacy. Dr.
Dalton was inducted into the Black CEO Hall of Fame in 2006. Honored by his
hometown of Grafton, West Virginia as author of city slogan Grafton, West Virginia
“ Birthplace of Mother’s Day “ He was inducted into the Taylor County School's
Hall of Fame in 2013. He was inducted into the West Virginia University School of
Pharmacy Centennial Hall of Fame in 2014 and Selected "Top 100 Healthcare
Leaders Worldwide " by IFAH 2019 and Top 100 Healthcare Visionary 2021
Contact:
David Dalton
UNIVEC, INC.
300 East Lombard St
Suite 1700
Baltimore, MD 21202
Phone:443-253-0194
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Do the DD
Links to